Aggressive Pricing Pinches Walgreens Margins
We're maintaining our fair value estimate as the firm discounts its generic inventory to win business and tries to close the Rite Aid acquisition.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.